1 Preimmunization activity could have been due to prior in
2 red for high frequencies of fetus loss after
preimmunization against paternal tissue Ags.
3 tumor emergence setting, however, for which
preimmunization against tumor Ags is sufficient for comp
4 Patients were evaluated
preimmunization and 12 weeks postimmunization for diseas
5 Preimmunization and postimmunization sera underwent stra
6 The effects of
preimmunization and tolerization with these epitopes on
7 nt intravesical instillations with KLH after
preimmunization,
and 270 patients were randomly assigned
8 inity contributes to positive selection of a
preimmunization B cell repertoire, whereas high-affinity
9 specific CTLs were detected in post- but not
preimmunization blood.
10 es on the tumor cells after transfection and
preimmunization by full-thickness skin grafts was requir
11 perglycemic (> 200 mg/dl) after intrahepatic
preimmunization by injection of 200 low-temperature cult
12 ostimmunization CD4(+) T cells compared with
preimmunization CD4(+) T cells.
13 Likewise, the PPS-specific B cells obtained
preimmunization consisted primarily of naive, CD27(-) B
14 Significantly,
preimmunization does not eliminate systemic vector-induc
15 cages, and stereotypy was rated to determine
preimmunization drug response (baseline).
16 Rats receiving peripheral
preimmunization followed by Ag into caudate nucleus have
17 The
preimmunization geometric mean (GM) Type 5 antibody leve
18 ed rapidly from 0.025% before challenge to a
preimmunization level of 0.0003% of CD4(+) T cells.
19 SFC/10(6) PBMC; p = 0.010), as compared with
preimmunization levels, were observed.
20 by postimmunization PBMC when compared with
preimmunization levels.
21 found to increase bactericidal activity over
preimmunization levels.
22 no shared epitope specificities between the
preimmunization memory compartment and responses detecte
23 tched epitopes detected in the corresponding
preimmunization memory repertoires, and clonotypes were
24 used in repeated vaccination, we report that
preimmunization of animals with Ad infected DCs prior to
25 Further studies revealed that
preimmunization of BUB mice with V beta 10 peptide alone
26 Preimmunization of C57BL/6 mice with one of the two type
27 Moreover,
preimmunization of mice by systemic exposure to adenovec
28 Preimmunization of mice with a panel of selected vaccine
29 Preimmunization of mice with this peptide substantially
30 Preimmunization of susceptible mice with VPI and VP2 fus
31 s was to investigate the effects of vimentin
preimmunization on allogeneic and isografted hearts in a
32 reased from 6.6 per 1000 patient-days in the
preimmunization period to 14.0 per 1000 patient-days in
33 reased from 5.4 per 1000 patient-days in the
preimmunization period to 19.3 per 1000 patient-days in
34 ization CD4(+) T cells compared with that in
preimmunization peripheral blood mononuclear cells.
35 compared with the identical, early-pandemic,
preimmunization predecessor study.
36 Additionally, results demonstrate that
preimmunization production of IL-4 after ex vivo whole b
37 lants was not significantly improved by this
preimmunization protocol at either transplantation site.
38 ted growth compared with tumors treated with
preimmunization rabbit antisera.
39 ained normoglycemia for > 100 days after the
preimmunization regimen.
40 Preimmunization resulted in high levels of circulating N
41 Dilutions of
preimmunization sera given i.p. 2 h before the bacterial
42 A production and in the return of IgM XNA to
preimmunization serum levels, 3 to 7 days after xenotran
43 st to just 5 to 10% inhibition obtained with
preimmunization serum.
44 Preimmunization titers against H3 HA pseudoviruses conta
45 The samples were chosen based on low
preimmunization titers and strong postimmunization respo
46 lantation, and it has been hypothesized that
preimmunization to antigens on transfused blood may prim
47 e GM lgM level, in contrast, declined to the
preimmunization value.
48 Q); in contrast, 36%-63% of the subjects had
preimmunization values of antibodies to FHA, PRN, or FIM
49 Of the subjects, 16%-19% had
preimmunization values of antibodies to PT that were abo
50 d across a full MHC mismatch by intrahepatic
preimmunization with a small number of cultured donor is
51 f autoimmune response to PLP 139-151 because
preimmunization with A144 to expand the L141/G142-reacti
52 After
preimmunization with Ag-alphaCD180 and boosting with sol
53 Preimmunization with CM but not control ovalbumin abroga
54 did not cross-react with donor antigens and
preimmunization with CM had no impact on the survival or
55 he observation that the protective effect of
preimmunization with KLH was overcome by rm-IL-12, which
56 Furthermore,
preimmunization with L144/R147 protected mice from EAE i
57 PIA) and those protected from the disease by
preimmunization with mycobacterial 65-kDa heat shock pro
58 Intriguingly,
preimmunization with rAAV8-hAAT vector or with serum of
59 ne transfer of factor IX was not impacted by
preimmunization with the other AAV serotypes.
60 otected against live TS/A tumor challenge by
preimmunization with TS/A admixed with C. parvum.
61 Mice free of clinical symptoms following
preimmunizations with fusion proteins displayed high lev
62 To investigate if
preimmunization would increase the level of protection a